As pharmaceutical companies strive to maintain competitive margins amidst increasing pressures, Gansons has a solution to offer. Mr. Ashis Banerjee says, Gansons helps clients not only meet current demands but also prepare for future challenges in the ever-evolving pharmaceutical landscape. Pharmaceutical companies are increasingly pressured by rising operational costs, stringent regulatory requirements, and the need for innovation. As a result, maintaining profitability while ensuring high-quality production has become a daunting task. The demand for more efficient processes and cost-effective solutions is at an all-time high. See the video below to learn how Gansons is helping pharmaceutical companies navigate depleting margins. Also if you want to experience the Gansons advantage, Join us at CPHI & PMEC India, Booth No. 9B-06, at India Expo Mart (IEML), Greater Noida, Delhi NCR, from 26th to 28th November 2024 and experience innovation that truly matters. Register at the link below. https://bit.ly/3YmkshE #CPHIIndia #PMECIndia #PharmaEfficiency #PharmaMachinery #GansCoater #TabletCoatingMachine #GranulationEquipment #WetGranulation #FBD #inOne #HighShearMixer #PharmaSolutions #PharmaIndustry #PharmaManufacturing #Exhibition #RDMachine #GansonsGoesOn
Gansons’ Post
More Relevant Posts
-
The West zone is paving the way with impressive double-digit growth in the Indian Pharmaceutical Market. Explore Pharmarack's latest industry report to uncover how all zones are driving positive value growth across India. Source: Acquaint June 24 #Pharmarack #IndianPharmaceuticalMarket #Marketinsights #Industryanalysis #Regionalinsights
To view or add a comment, sign in
-
Addressing the Challenge of Substandard Drugs in Today’s Market: In recent times, the issue of drugs Not of Standard Quality or substandard drugs has become a significant concern in the pharmaceutical industry. These drugs fail to meet the required quality standards, posing serious health risks to patients and undermining trust in healthcare systems. The proliferation of NSQ drugs can be attributed to various factors, including inadequate regulatory oversight, poor manufacturing practices, and the complexity of global supply chains. It is crucial for stakeholders, including regulatory bodies, pharmaceutical companies, and healthcare professionals, to collaborate and implement stringent quality control measures. By enhancing regulatory frameworks, investing in advanced manufacturing technologies, and promoting transparency in overall process, we can work towards ensuring that every patient receives safe and effective medication. Let’s join hands to combat this pressing issue and safeguard public health. #PharmaceuticalIndustry #Healthcare #DrugSafety #QualityControl #PublicHealth
To view or add a comment, sign in
-
𝐇𝐨𝐰 𝐌𝐮𝐫𝐥𝐢 𝐊𝐫𝐢𝐬𝐡𝐧𝐚 𝐏𝐡𝐚𝐫𝐦𝐚 𝐢𝐬 𝐑𝐞𝐝𝐞𝐟𝐢𝐧𝐢𝐧𝐠 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝𝐬 𝐢𝐧 𝐈𝐧𝐝𝐢𝐚 With a client base of over 200, including more than 64 leading international companies, and a turnover exceeding US$ 6 million, Murli Krishna Pharma Pvt. Ltd. is making significant impact in the pharmaceutical industry in India, while setting new benchmarks and redefining standards. Murli Krishna Pharma’s performance speaks of its capabilities, with a cumulative growth of over 60% in the last three years. As a young and dynamic drug delivery systems (DDS) company in India, MKPPL provides a range of effective solutions to optimize the delivery of pharmaceutical preparations. Established in 2004 by Dr. Satya Vadlamani and Dr. Vijay K. Shastri, the company is driven by the vision to provide the best possible range of international quality products at competitive prices through integration, research, innovation, technology, and development. Read More: https://lnkd.in/ghch_cFw #Murlikrishnapharma #PharmaInnovation #HealthcareRevolution #IndianPharma #QualityHealthcare #PharmaExcellence #RedefiningPharma #MurliKrishnaPharma #PharmaceuticalStandards #PharmaLeadership #InnovativeMedicine #HealthcareStandards #PharmaPioneers #FutureOfPharma #HealthTech #PharmaSuccess
To view or add a comment, sign in
-
India’s Penicillin-G Revival! 💊 After three decades, India is set to relaunch domestic Penicillin-G production, with Aurobindo Pharma leading the charge. With PM inaugurating the new plant in Andhra Pradesh, this initiative is expected to reduce India's reliance on imports and strengthen its pharmaceutical supply chain. Discover the impact of this milestone on India’s healthcare sector and how government incentives like the PLI scheme are reshaping API production. For more research like this follow Penguin International 📲 #Pharmaceuticals #PenicillinG #IndianIndustry #SelfReliance #APIProduction #AurobindoPharma #Healthcare #ConsultingResearch #PenguinInternational"
To view or add a comment, sign in
-
💊 The Pharma Patent Cliff: Opportunities Await! 🌐 As major drugs lose exclusivity in the coming years, a golden window opens for Indian pharmaceutical companies to step in with high-quality, affordable generics. 🚀 From 2025 to 2037, billions in market potential are up for grabs. India’s robust pharma industry is poised to shine brighter than ever! 🇮🇳💼💊 #PharmaPatentCliff #PharmaceuticalIndustry #Generics #IndianPharma #BrightFuture #HealthcareOpportunities #PharmaGrowth #DrugExclusivity #PharmaTrends #Innovation #AffordableMedicine #IndiaPharmaPower #GlobalPharma #MakeInIndia #GenericsOpportunities #HealthcareInnovation #PharmaLeaders #BusinessGrowth #HealthcareFuture
To view or add a comment, sign in
-
In today's day and age, pharmaceutical equipment manufacturers are not just engineering companies but are technology partners for pharmaceutical companies. Mr. Ashis Banerjee states that Gansons has already moved itself ahead of the curve and is actively working with global pharmaceutical manufacturers by emphasizing on continuous cost effectiveness, increased operational efficiencies and anticipating equipment related regulatory hurdles. With an emphasis on pre-empting regulatory hurdles, global equipment manufacturers not only need to deliver world-class engineered equipment but also delve into regulatory support to pharmaceutical manufacturers. See the video below to get a glimpse on how Gansons has developed from being an equipment manufacturer to a technology partner to pharmaceutical companies. Also, if you want to experience innovations that actually deliver, join us at CPHI & PMEC India, Booth No. 9B-06, at India Expo Mart (IEML), Greater Noida, Delhi NCR, from 26th to 28th November 2024 and experience innovation that truly matters. Register at the link below. https://bit.ly/3YmkshE #CPHIPMEC #PMEC2024 #PharmaEvent #PharmaceuticalEquipment #GlobalManufacturers #OperationalEfficiency #EquipmentManufacturers #TabletCoating #PharmaEquipmentManufacturer #TabletCoaterMachine #FluidBedDryer #inOne #HighShearMixer #GranulationEquipment #Knowledge #Execution #Support #WetGranulation #PharmaceuticalIndustry #PharmaManufacturing #PharmaceuticalSolutions #InnovationThatMatters #GansonsGoesOn
To view or add a comment, sign in
-
The Department of Pharmaceuticals has recently issued the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024. Varsha Rajesh in conversation with The Hindu businessline points to how executive heads of companies are required to submit a self-declaration regarding compliance with the UCPMP to their respective industry associations. She further elaborates that the Code makes it mandatory for CME conferences to be conducted in India, not at company premises and hotels overseas (as was a common industry practice). The Code further outlines that CMEs be allowed through transparent and verifiable guidelines published on the company website. https://lnkd.in/gShHPqcM #pharma #pharmamarketing #pharmaceutical #healthcare #marketing
To view or add a comment, sign in
-
Pharma Sector Calls for Lifting Price Cap Rule on Low-Cost Drugs The pharmaceutical industry is urging for the removal of price cap regulations on affordable medications. Read more about the ongoing debate and its potential impact on healthcare costs and accessibility. 🏥💊 🔗 Read the full article: https://lnkd.in/gTqijUNK . . . . . . . . . . . . . . . . . . .. . #Pharma #Healthcare #DrugPricing #MedicalNews #AffordableMedicine MedBound Times MedBound Priyanka Pandey
To view or add a comment, sign in
-
🔬 **Enhancing Drug Safety: Minimizing Nitrosamines in Pharmaceuticals** 🌍 With increasing scrutiny on nitrosamines—potentially harmful impurities—it's crucial for pharmaceutical manufacturers to safeguard public health. ✨ **Key Takeaways:** - Choose high-purity raw materials - Optimize manufacturing processes - Utilize advanced detection methods - Implement continuous monitoring - Adjust formulation pH to reduce nitrosamine risk By adopting these measures, we can improve medicine quality and foster greater industry trust. and now answer this question: https://lnkd.in/dUFRKbaB Also visit: https://lnkd.in/dWbb9-cJ #Pharmaceuticals #DrugSafety #Nitrosamines #QualityControl #Healthcare
To view or add a comment, sign in
-
Get more info @ https://lnkd.in/dCRB4dxP The pharmaceutical packaging market is set to grow significantly in 2024, driven by the aging population, advances in drug delivery, and stricter regulatory requirements. Innovations include smart packaging with #QRcodes and #ecofriendly materials. #northamerica leads the market, while #AsiaPacific shows rapid growth. Key players are West Pharmaceutical Services, Berry Global, Inc., Amcor Limited, and Gerresheimer AG. The global pharmaceutical packaging market size is estimated to be USD 132.0 billion in 2023 and projected to reach USD 269.9 billion in 2028, at a CAGR of 15.4%. #pharmapackaging #drugpackaging #packaginginnovation #smartpackaging #sustainablepackaging #healthcare
To view or add a comment, sign in
13,125 followers